Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors
- PMID: 23179993
- PMCID: PMC3856190
- DOI: 10.1245/s10434-012-2739-y
Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors
Abstract
Background: Excellent long-term outcomes have been reported recently for patients with small (≤2 cm) hepatocellular carcinoma (HCC). However, the significance of microvascular invasion (MVI) in small HCC remains unclear. The purpose of this study was to determine the impact of MVI in small HCC up to 2 cm.
Methods: In 1,109 patients with solitary HCC from six major international hepatobiliary centers, the impact of MVI on long-term survival in patients with small HCC (≤2 cm) and patients with tumors larger than 2 cm was analyzed.
Results: In patients with small HCC, long-term survival was not affected by MVI (p = 0.8), whereas in patients with larger HCC, significantly worse survival was observed in patients with MVI (p < 0.0001). In multivariate analysis, MVI (hazard ratio [HR] 1.59; 95 % confidence interval (CI) 1.27-1.99; p < 0.001), elevated alpha-fetoprotein (HR 1.41; 95 % CI 1.11-1.8; p = 0.005), and higher histologic grade (HR 1.29; 95 % CI 1.01-1.64; p = 0.04) were significant predictors of worse survival in patients with HCC larger than 2 cm but were not correlated with long-term survival in small HCC. When the cohort was divided into three groups-HCC ≤2, >2 cm without MVI, and HCC >2 cm with MVI-significant between-group survival difference was observed (p < 0.0001).
Conclusions: Small HCC is associated with an excellent prognosis that is not affected by the presence of MVI. The discriminatory power of the 7th edition of the AJCC classification for solitary HCC could be further improved by subdividing tumors according to size (≤2 vs. >2 cm).
Conflict of interest statement
Figures



Similar articles
-
Effects of genomic changes in hepatitis B virus on postoperative recurrence and survival in patients with hepatocellular carcinoma.Ann Surg Oncol. 2013 Apr;20(4):1216-22. doi: 10.1245/s10434-012-2706-7. Epub 2012 Oct 27. Ann Surg Oncol. 2013. PMID: 23104706 Free PMC article.
-
The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients.J Gastrointest Surg. 2015 Jul;19(7):1281-90. doi: 10.1007/s11605-015-2849-5. Epub 2015 May 9. J Gastrointest Surg. 2015. PMID: 25956724
-
Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysis.HPB (Oxford). 2019 Aug;21(8):935-944. doi: 10.1016/j.hpb.2019.02.003. Epub 2019 Mar 11. HPB (Oxford). 2019. PMID: 30871805
-
Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis.Biomed Res Int. 2020 Oct 17;2020:1487593. doi: 10.1155/2020/1487593. eCollection 2020. Biomed Res Int. 2020. PMID: 33134370 Free PMC article.
-
Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition).Hepatobiliary Surg Nutr. 2025 Apr 1;14(2):246-266. doi: 10.21037/hbsn-24-359. Epub 2024 Dec 30. Hepatobiliary Surg Nutr. 2025. PMID: 40342785 Free PMC article. Review.
Cited by
-
Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients.Ann Transl Med. 2021 Mar;9(5):402. doi: 10.21037/atm-20-4695. Ann Transl Med. 2021. PMID: 33842623 Free PMC article.
-
Inappropriate inferences from registry data: Pitfalls of inaccurate data handling?Indian J Gastroenterol. 2017 Mar;36(2):77-80. doi: 10.1007/s12664-017-0749-1. Epub 2017 Mar 30. Indian J Gastroenterol. 2017. PMID: 28357774 No abstract available.
-
Tumor Size Does Not Affect Survival Outcomes of Patients Undergoing Resection for a Single Hepatocellular Carcinoma Without Microscopic Vascular Invasion in the Modern Era of Antiviral Therapy.Dig Dis Sci. 2025 Jul 24. doi: 10.1007/s10620-025-09254-x. Online ahead of print. Dig Dis Sci. 2025. PMID: 40705244
-
Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.Oncologist. 2019 Apr;24(4):513-520. doi: 10.1634/theoncologist.2018-0305. Epub 2018 Dec 14. Oncologist. 2019. PMID: 30552155 Free PMC article.
-
Development and Validation of Novel Models Including Tumor Micronecrosis for Predicting the Postoperative Survival of Patients with Hepatocellular Carcinoma.J Hepatocell Carcinoma. 2023 Jul 25;10:1181-1194. doi: 10.2147/JHC.S423687. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37521028 Free PMC article.
References
-
- Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
-
- Kee KM, Wang JH, Lee CM, Chen CL, Changchien CS, Hu TH, et al. Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer. 2007;120:2650–2655. - PubMed
-
- Lei HJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, et al. Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. J Am Coll Surg. 2006;203:426–435. - PubMed
-
- Poon RT, Fan ST. Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. Surg Oncol Clin N Am. 2003;12:35–50. viii. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical